The global automotive speaker market is projected to reach USD 12.92 billion in 2029, at a CAGR of 6.4% during the forecast period. The automotive speaker market includes significant Tier I and II players like Panasonic Holdings Corporation (US), Bose Corporation (US), Samsung Electronics Co., Ltd. (South Korea), Alps Alpine Co., Ltd. (Japan), Pioneer Corporation (Japan), Sony Group Corporation (Japan), Masimo Corporation (US), Clarion (US), Focal (France), Elettromedia S.p.A. (Italy), JVC KENWOOD Corporation (Japan), Stillwater Designs (US), Rockford Corp. (US) are some of the key players in the automotive speaker market.
The ultralight and light aircraft market is projected to reach USD 17.29 billion by 2029 at a CAGR of 11.2% during the forecast period. Major players operating in the ultralight and light aircraft market are Bell Helicopters (US), Pilatus Aircraft(Switzerland), Air Tractor (US), Flight Design General Aviation (Germany), ,Textron Inc. (US) , Aeropro (Slovakia), Autogyro (Germany).These key players offer ultralight and light aircrafts across regions, and have well-equipped and strong distribution networks across the North American, European, Asia Pacific, Latin American, Middle East and African regions.
The more electric aircraft market is expected to grow from USD 5.56 billion in 2024 to USD 8.01 billion by 2029, at a CAGR of 7.6% during the forecast period. The key market players in the more electric aircraft market are S.A ( France), Honeywell International Inc. (US), RTX (US), General Electric (US), Parker Hannifin Corporation (US), Bae Systems plc (UK),Bomardier Inc. (Canada), Embraer S.A (Brazil), Liebherr (Switzerland), Ametek Inc. (US), Astronics Corporation (US), Moog inc. (US), Rolls-Royce Plc (UK), Amphenol Corporation (US), Eaton (Ireland).
The plastic injection molding machine market is expected to grow from USD 11.98 billion in 2024 to USD 14.78 billion by 2030, at a CAGR of 3.56% during the forecast period. The key players profiled in the report include Haitian International Holdings Limited (China), Chen Hsong Holdings Ltd. (China), Engel Austria GmbH (Austria), Sumitomo Heavy Industries Limited (Japan), Hillenbrand, Inc. (US), Japan Steel Works Ltd. (Japan), Arburg GmbH (Germany), Nissei Plastic Industrial Co., Ltd. (Japan), Husky Injection Molding Systems Ltd. (Canada), and KraussMaffei Group GmbH (Germany).
The satellite communication (SATCOM) equipment market is expected to grow from USD 24.27 billion in 2024 to USD 41.51 billion by 2029, at a CAGR of 11.3% during the forecast period. The SATCOM equipment market is dominated by a few globally established players such Echostar Corporation (US), L3Harris Technologies, Inc. (US), Thales (France), RTX (US), General Dynamics Corporation (US), Cobham Satcom (Denmark), Honeywell International Inc. (US), Viasat, Inc. (US), Gilat Satellite Networks (Israel), Aselsan A.S (Turkey), Iridium Communication Inc. (US), Intellian Technologies Inc. ( South Korea), ST Engineering (Singapore), SpaceX (US), Elbit Systems Ltd. (Israel), Campbell Scientific, Inc. (US), ND SatCom GmbH ( Germany), among others.
The Hybrid UAV is projected to reach 1705.0 million by 2030, at a CAGR of 14.4% during the forecast period. Key players in this market include Northrop Grumman (US), Thale (France), L3Harris Technologies, Inc., (US) ), JOUAV (China), Elroy Air (US), Draganfly (Canda), Pipistrel (Italy), Harris Aerial (US), Natilus (US), Doosan Mobility Innovation (South Korea) Moya aero (Brazil), Waveaerospace (US), Aeronautics (Israel), Skyfront (US), Xer Technologies. Avartek (UK), ElevonX (US), ALTI Unmanned (South Africa) and Elbit Systems Ltd. (Israel) among others.
The global shore power market is projected to reach USD 3.58 billion by 2029, growing at a CAGR of 12.0% during the forecast period. The world shore power market is influenced by strategic moves of key players, including ABB (Switzerland), Siemens (Germany), Schneider Electric (France), GE (US), and Cavotec SA (Switzerland), which focus on developing shore power solutions with the state-of-the-art technology to fully meet demand from ports regarding cleaner and more efficient energy supply. Some of the strategies include very innovative products such as advanced frequency converters and energy management systems to reduce emissions from docked ships. Other major approaches towards the expansion of their technological capability and increasing market reach are acquisitions and partnerships by which they can cater to more diverse geographic regions and stricter environmental regulations across the globe.
The market for vector control is projected to reach USD 28.58 billion by 2029, at a CAGR of 6.2% during the forecast period. The report profiles key players such as BASF SE (Germany), Rentokil Initial Plc (UK), Sumitomo Chemical Co., Ltd. (Japan), Syngenta Group (Switzerland), FMC Corporation (US), Ecolab (US), Rollins Inc. (US), Anticimex (Sweden), UPL (India), Neogen Corporation (US), Senestech, Inc. (US), Environmental Science U.S. Inc. (US), Bell Laboratories Inc. (US), Pelgar International (UK), S. C. Johnson & Son, Inc. (US).
The phosphate market is expected to grow from USD 180.99 billion in 2024 to USD 219.74 billion by 2029, at a CAGR of 3.9% during the forecast period. The key players profiled in the report include OCP Group S.A. (Morocco), The Mosaic Company (US), PhosAgro Group of Companies (Russia), Ma’aden (Saudi Arabia), Nutrien Ltd. (Canada), EuroChem Group (Switzerland), Innophos Holdings, Inc. (US), Jordan Phosphate Mines Company (PLC) (Jordan), Kazphosphate LLP (Kazakhstan), ICL Group Ltd. (ICL) (Israel), Wengfu Group Co., Ltd. (China), Yara (Norway), and Yuntianhua Group Co., Ltd. (China).
The global gene editing market growth is primed to transition from USD 4.66 billion in 2024 to USD 7.59 billion by 2029, showcasing a strong CAGR of 10.2%. The main factors driving the expansion of this market are the demand for personalized medicine and favorable government funding for gene editing projects. Additionally, the expanding range of gene editing applications, spurred by technological advancements in prime editing and CRISPR RNA, along with the growing burden of congenital diseases, are also contributing to the market's growth.
The AI in supply chain market is projected to reach USD 40.53 billion by 2030, at a CAGR of 28.2% during the forecast period. Leading players in the AI in Supply Chain market include SAP SE (Germany), Oracle (US), Blue Yonder Group, Inc. (US), Kinaxis Inc. (Canada), Manhattan Associates (US), IBM (US), Microsoft (US), Anaplan, Inc. (US), ServiceNow (US), e2open, LLC (US) are few other key companies operating in the AI in supply chain market.
The global healthcare IT market growth is primed to transition from USD 420.23 billion in 2024 to USD 834.35 billion by 2029, showcasing a strong CAGR of 14.7%. Increasing returns on investments in healthcare IT solutions for hospitals and clinics are the main drivers of market growth. As healthcare costs continue to rise, these IT solutions help improve efficiency and reduce expenses in healthcare settings, encouraging the adoption of new technologies that enhance care while saving money.
The global refrigeration coolers market is projected to reach USD 5.74 billion by 2029, registering a CAGR of 6.5% during the forecast period. The refrigeration coolers market includes significant Tier I and II players such Johnsons Controls (Ireland), Lennox International (US), Lu-Ve Group(Italy), Rivacold (Italy),Kelvion Holding GmBH (Germany), Modine Manufacturing (US) and Copeland (US), among others.
The energy recovery ventilator core market is expected to grow from USD 1.01 billion in 2024 to USD 1.56 billion by 2030, at a CAGR of 7.4% during the forecast period. Some of the leading players in this market include CORE Energy Recovery Solutions (Germany), HOLTOP (China), Greenheck Fan Corporation (US), Ruskin (US), and Innergy Tech Inc. (Canada).
The global AI in drug discovery market growth is primed to transition from USD 1.86 billion in 2024 to USD 6.89 billion by 2029, showcasing a strong CAGR of 29.9%. The growth of this market is primarily driven by the growing number of cross-industry collaborations and partnerships, the need to control drug discovery & development costs and reduce the overall time taken in this process, and the increasing focus on oncology indication.